health characteristics of patients with asthma, COPD and asthma–COPD overlap in the nhanes database

Introduction: Asthma and COPD have overlapping characteristics. As there are limited data on whether asthma–COPD overlap (ACO) represents a distinct condition, this study aimed to determine the similarities and differences of ACO with asthma and COPD. Methods: US population-based, cross-sectional study using National Health and Nutrition Examination Survey data (2009–2012) compared participants with ACO vs those with asthma or COPD, each as mutually exclusive disease states. Demographics, health status, disability/ limitations, health care resource utilization, clinical characteristics, and peripheral blood eosinophil counts were analyzed. Results: A total of 1,609, 479, and 299 participants with asthma, COPD, and ACO, respectively, were included. An age-matched asthma subgroup included 299 participants from the asthma group. Compared with asthma and COPD, participants with ACO had worse health status, increased disease burden, and more comorbid conditions. The ACO, vs age-matched asthma subgroup, had lower percent predicted prebronchodilator forced expiratory volume in 1 second (82.1% vs 88.0%; P = 0.017). The ACO group had significantly more asthma attacks in the past year than the age-matched asthma subgroup (49.8% vs 38.4%; P , 0.001). The ACO group had more participants with postbronchodilator forced expiratory volume in 1 second , 80% predicted (52.1%) vs COPD (30.8%; P = 0.003) and more participants with blood eosinophil counts $ 400 cells/ µ L (16.9%) vs COPD (9.5%; P = 0.007) and the asthma subgroup (6.7%; P = 0.014). Conclusion: The ACO group represents an important subset of patients with chronic respiratory disease with an increased burden of disease over asthma and COPD individually. Early identification of this population will enable appropriate therapeutic interventions in a timely manner.

[1]  J. Lötvall,et al.  Prevalence, clinical characteristics and morbidity of the Asthma-COPD overlap in a general population sample , 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

[2]  I. Pavord,et al.  Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease , 2017, The New England journal of medicine.

[3]  D. Lynch,et al.  American Thoracic Society/National Heart, Lung, and Blood Institute Asthma‐Chronic Obstructive Pulmonary Disease Overlap Workshop Report , 2017, American journal of respiratory and critical care medicine.

[4]  S. Morita,et al.  Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach , 2017, International journal of chronic obstructive pulmonary disease.

[5]  D. Kim,et al.  Different prevalence and clinical characteristics of asthma-chronic obstructive pulmonary disease overlap syndrome according to accepted criteria. , 2017, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[6]  R. Peebles,et al.  Management of the Asthma-COPD Overlap Syndrome (ACOS): a Review of the Evidence , 2017, Current Allergy and Asthma Reports.

[7]  A. Tjønneland,et al.  Incidence and long-term outcome of severe asthma–COPD overlap compared to asthma and COPD alone: a 35-year prospective study of 57,053 middle-aged adults , 2017, International journal of chronic obstructive pulmonary disease.

[8]  C. Camargo,et al.  Fractional exhaled nitric oxide levels in asthma–COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007–2012 , 2016, International journal of chronic obstructive pulmonary disease.

[9]  N. Chavannes,et al.  Defining asthma–COPD overlap syndrome: a population-based study , 2016, European Respiratory Journal.

[10]  Christopher E Brightling,et al.  Severe eosinophilic asthma treated with mepolizumab stratified by baseline eosinophil thresholds: a secondary analysis of the DREAM and MENSA studies. , 2016, The Lancet. Respiratory medicine.

[11]  B. Nordestgaard,et al.  Blood Eosinophils and Exacerbations in Chronic Obstructive Pulmonary Disease. The Copenhagen General Population Study. , 2016, American journal of respiratory and critical care medicine.

[12]  M. van den Berge,et al.  The asthma–COPD overlap syndrome: how is it defined and what are its clinical implications? , 2016, Journal of asthma and allergy.

[13]  Vicki L Burt,et al.  National health and nutrition examination survey: sample design, 2011-2014. , 2014, Vital and health statistics. Series 2, Data evaluation and methods research.

[14]  D. Mannino,et al.  Chronic Obstructive Pulmonary Disease and Asthma–Patient Characteristics and Health Impairment , 2013, COPD.

[15]  Vicki L Burt,et al.  National Health and Nutrition Examination Survey: sample design, 2007-2010. , 2013, Vital and health statistics. Series 2, Data evaluation and methods research.

[16]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[17]  Joyce D. Schroeder,et al.  The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.

[18]  W. Bailey,et al.  Global initiative for chronic obstructive lung disease. , 2002, Journal of cardiopulmonary rehabilitation.

[19]  D. Labarthe,et al.  Rise of blood pressure with age. New evidence of population differences. , 1994, Hypertension.

[20]  S. Peters,et al.  Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[21]  C. Lenfant,et al.  Global Initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease , 2006 .